Ensign Peak Advisors
MGNX icon

Ensign Peak Advisors’s MacroGenics MGNX Stock Holding History

Ensign Peak Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,820
Closed -$41K – 2046
2022
Q3 		$41K Buy
+11,820
New +$45.2K ﹤0.01% 2248
2022
Q2 		– Sell
-13,440
Closed -$118K – 2186
2022
Q1 		$118K Buy
13,440
+460
+4% +$5.08K ﹤0.01% 1996
2021
Q4 		$208K Buy
+12,980
New +$244K ﹤0.01% 1918

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Ensign Peak Advisors's MGNX Position: Q4 2022 in Review

Ensign Peak Advisors sold out of MacroGenics (MGNX) in Q4 2022, closing a stake of 11,820 shares — an estimated $41K sold.

Ensign Peak Advisors first reported a position in MGNX in Q4 2021 and held it in 3 quarters. The position peaked at $208K in Q4 2021. 135 funds tracked by Wall St. Rank hold MGNX as of Q4 2022.

  • Ensign Peak Advisors reported no remaining MacroGenics position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 11,820 MacroGenics shares in Q4 2022, an estimated $41K.
  • Ensign Peak Advisors first reported a position in MacroGenics in Q4 2021 and held it in 3 quarters.
  • Ensign Peak Advisors's MacroGenics position peaked at $208K in Q4 2021.
  • 135 funds tracked by Wall St. Rank held MacroGenics as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.